The claim
A farmacêutica japonesa Kowa anunciou nesta segunda-feira (31) que o medicamento antiparasitário ivermectina foi considerado eficaz no tratamento da variante Omicron do COVID-19 em um estudo de Fase III.
Sources and attribution
- [S1] Boatos.org original review
Original review · Retrieved October 15, 2026
Original review: Boatos.org. Structured data compiled by Data Commons under CC BY 4.0. Publisher article content is subject to its own terms.
Updated